Advaxis305 College Road East Princeton, NJ 08540eMail:Website:https://www.advaxis.comLatest from AdvaxisOral CancerFDA awards $1.1M for immunotherapy researchBy DrBicuspid.com staff writersThe U.S. Food and Drug Administration (FDA) has awarded a $1.1 million grant for research on oropharynx cancer related to human papillomavirus.September 13, 2015HomeDrB_OrphanedArticles_from_keyword_adjustments_v5_2015_0220January 31, 2015HomeDrB_OrphanedArticles_from_keyword_adjustments_v4_2015_0218January 31, 2015Immune SystemAdvaxis, MedImmune partner on clinical trialBy DrBicuspid.com staff writersAdvaxis, a biotechnology company that develops cancer immunotherapies, has entered a clinical trial collaboration with MedImmune, the biologics research and development arm of AstraZeneca.July 21, 2014Oral CancerAdvaxis drug targets HPV-associated head/neck cancerBy DrBicuspid.com staff writersAdvaxis, a developer of immunotherapies for cancer and infectious diseases, has submitted an application for orphan drug designation with the U.S. Food and Drug Administration for ADXS-HPV for the treatment of human papillomavirus (HPV)-associated head and neck cancer.June 11, 2013